期刊文献+

速效救心丸对动脉粥样硬化大鼠干预作用的实验研究 被引量:6

Effect of Suxiao Jiuxin Wan on the expressions of oxLDL,NF-kb and PPARγ in rats with arteriosclerosis
下载PDF
导出
摘要 [目的]研究速效救心丸对动脉粥样硬化(AS)组织中氧化型低密度脂蛋白(ox-LDL)、过氧化物酶体增殖激活受体γ(PPARγ)和核因子-κb(NF-κb)表达的影响。[方法]采用高脂饮食加大剂量钙负荷建立大鼠AS模型,随机分为正常组、模型组、速效救心丸治疗组、阿托伐他汀组,采用酶联免疫吸附实验(ELASA)测定ox-LDL含量;Western-blot测定PPARγ和NF-κb蛋白的表达。[结果]模型组ox-LDL的含量、PPARγ和NF-κb的蛋白表达较正常组均显著升高;速效救心丸治疗组ox-LDL的含量、PPARγ及NF-κb的蛋白表达较模型组均明显下降。[结论]速效救心丸能明显降低ox-LDL含量,抑制PPARγ和NF-κb的蛋白表达,可能是其防治AS的机制之一。 [0bjective] To investigate the effects of Suxiao Jiuxin (treating cardiac disease with rapid effect) Wan on the expressions of oxLDL,NF-κb and PPARγ.[Methods] Experimental arteriosclerosis (AS) in rats was produced by feeding with high fat diet and vitamin D3. The AS rats were randomly divided into the normal group, the model group, the Suxiao Jiuxin Wan treated group and astorvastatin treated group. The serum levels of ox-LDL were measured by ELISA method. The protein of NF-κb and PPARγ was measured by Western blot. [Results] In the model group, the content of ox-LDL, the protein of NF-κb and PPARγ was increased compared with the normal group; Compared with the model group, the content of ox-LDL the protein of NF-κb and PPARγ were declined in Suxiao Jiuxin Wan groups. [Conclusions] Suxiao Jiuxin Wan may prevent the development of arteriosclerosis .The decreasing of ox-LDL and the inhibiting of the expression of NF-κb and PPARγ may contribute to the prevention.
出处 《天津中医药》 CAS 2009年第6期486-488,共3页 Tianjin Journal of Traditional Chinese Medicine
关键词 速效救心丸 动脉粥样硬化 氧化型低密度脂蛋白 过氧化物酶体增殖激活受体 核因子-ΚB Suxiao Jiuxin Wan arteriosclerosis oxidized low lipoprotein peroxisome proliferators activated receptor-γ nuclear factor kappaB.
  • 相关文献

参考文献5

  • 1Ehara S,Ueda M ,Naruko T,et al.Pathophysiological role of oxidized low-density lipopmtein in plaque iustbility in coronary artery diseases [J].Diabetes Compfica, 2002,8 (16) :60-64.
  • 2Tsukamoto K, Kinoshita M, Kojima K, et al. Synergically increased expressioof CD36, CLA! and CD68, but not of SRA andLOX1, with the progression tfoam cellsfrom macrophage [J]. Atheroscler Thromb, 2002, 9 (1) : 57-64.
  • 3TontonozP, nagyL.Regulation of macrophage gene expression by peroxisotne-proliferator-activated receptor gamma implication for cardivascular disease[J]. Curr. Opin, Lipidoe, 1999, 10(6) : 485-490.
  • 4Maziere C, AuclairM, DavahergnyM, et al. Oxidized low density lipoprotein induces activation of thetranscription factorNF kappaB in fibroblasts, endothelial and smoothmuscle cells[J]. Bioctlem Mol- Biol Int,1996, 39(6): 1201-1207.
  • 5张京春,陈可冀,张文高,史大卓.不稳定斑块的中西医结合认识现状及研究思路[J].中国中西医结合杂志,2005,25(10):869-871. 被引量:52

二级参考文献15

  • 1李建军,李庚山.动脉粥样斑块破裂的研究进展[J].中华老年心脑血管病杂志,2000,2(4):273-278. 被引量:23
  • 2霍丽梅,宋光耀,叶蔚.脂联素与动脉粥样硬化[J].心血管病学进展,2005,26(3):299-302. 被引量:15
  • 3文川,徐浩,黄启福,陈可冀.活血中药对ApoE基因缺陷小鼠血脂及动脉粥样硬化斑块炎症反应的影响[J].中国中西医结合杂志,2005,25(4):345-349. 被引量:134
  • 4Ravn HB, Falk E. Histopathology of plaque rupture. Cardiol Clin 1999; 17(2): 263-270.
  • 5Libby P, Ridker PM, Maseri A. Inflammation and atherosclersis. Circulation 2002; 105: 1135- 1143.
  • 6Willerson JT,Ridker PM. Inflammation as a cardiovascular risk factor.Circulation 2004; 109: II2-II10.
  • 7Servoss SJ, Januzzi JL, Muler JE. Triggers of acute coronary syn dromes. Prog Cardiovasc Dis 2002;44(5):369-380.
  • 8Marx N, Duez H, Fruchart JC, et al. Peroxisome proliferator-activat ed receptors and atherogenesis: regulators of gene expression in vascu lar cells. CircRes 2004; 14;94(9):1168-1178.
  • 9Conti CR. Updated pathophysiologic concepts in unstable coronary artery disease. Am Heart J 2001; 141 ( 2 Suppl): S12- 14.
  • 10Dupuis J. Mechanisms of acute coronary syndromes and the potential role of statins. Atheroscler Suppl 2001; 2(1) :9-14.

共引文献51

同被引文献86

引证文献6

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部